Triple therapy shows promise for advanced nasopharyngeal cancer
NCT ID NCT05524168
First seen Jan 19, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tests a new treatment for nasopharyngeal cancer that has spread to up to 5 other places in the body. It combines precise radiation (SBRT) with an immunotherapy drug (PD-1 antibody) and chemotherapy. The goal is to see if this approach can control the cancer longer. The study involves 41 adults who have not had prior treatment for their metastatic disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.